Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
85 studies found for:    "Lupus nephritis"
Show Display Options
Rank Status Study
1 Withdrawn Velcade for Proliferative Lupus Nephritis
Conditions: Lupus Nephritis;   Proteinuria;   Hematuria
Intervention: Drug: Velcade
2 Completed Lupus Nephritis: Role of Environmental and Occupational Exposures
Condition: Lupus Nephritis
Intervention:
3 Completed Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients
Condition: Lupus Nephritis
Intervention:
4 Recruiting ACTHar in the Treatment of Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: CellCept;   Drug: Acthar gel
5 Completed Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune Study
Conditions: Systemic Lupus Erythematosus;   Lupus Nephritis
Interventions: Drug: Cyclosporine A;   Drug: Cyclophosphamide
6 Recruiting Functional MRI in Lupus Nephritis
Condition: Lupus Nephritis
Intervention:
7 Unknown  Effect of Mesenchymal Stem Cell Transplantation for Lupus Nephritis
Condition: Lupus Nephritis
Intervention: Biological: mesenchymal stem cell
8 Not yet recruiting RING - Rituximab for Lupus Nephritis With Remission as a Goal
Condition: Lupus Nephritis
Interventions: Drug: RTX  infusions;   Other: Standard of Care
9 Withdrawn Steroids in the Maintenance of Remission of Proliferative Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: prednisolone;   Drug: Placebo
10 Completed Cyclophosphamide and Fludarabine to Treat Lupus Nephritis
Conditions: Glomerulonephritis;   Lupus Nephritis;   Systemic Lupus Erythematosus
Intervention: Drug: SQ Fludarabine
11 Unknown  Clinical Trial Treatment in Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: cyclosporine +mycophenolic acid+prednison;   Drug: Mycophenolic Acid + prednison
12 Completed Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis
Conditions: SLE;   Lupus Nephritis;   Renal Insufficiency;   End-stage Renal Disease
Interventions: Drug: Tacrolimus;   Drug: cyclophosphamide
13 Completed
Has Results
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
Conditions: Lupus Nephritis;   Lupus Erythematosus, Systemic
Interventions: Drug: abatacept;   Drug: cyclophosphamide;   Drug: azathioprine;   Drug: prednisone;   Drug: abatacept placebo;   Drug: azathioprine placebo
14 Recruiting Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis
Condition: Lupus Nephritis
Intervention: Drug: Tacrolimus vs. Mycophenolate mofetil for Induction Therapy in Lupus Nephritis
15 Completed Safety and Efficacy on Deoxyspergualin (NKT-01) in Patients With Lupus Nephritis
Condition: Lupus Nephritis
Intervention: Drug: NKT-01
16 Completed Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative Study
Condition: Lupus Nephritis
Intervention: Drug: tacrolimus
17 Completed An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: CNTO 136;   Drug: Placebo
18 Completed Study to Assess the Efficacy and Safety of FK506 Combined With Mycophenolate Mofetil (MMF) in Lupus Nephritis (III/IV/V)
Condition: Lupus Nephritis
Intervention: Drug: Multitherapy
19 Completed Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Tacrolimus+Mycophenolate mofetil;   Drug: Cyclophosphamide
20 Terminated The Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) (Myfortic) in The Treatment of Relapse or Resistant Proliferative Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: mycophenolate sodium;   Drug: cyclophosphamide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years